Drug Profile
Research programme: opioid receptor agonists - Johnson and Johnson
Alternative Names: JNJ-20788560; RWJ-394674; RWJ-413216Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Janssen Research & Development
- Class
- Mechanism of Action Opioid delta receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory pain; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-pain in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in USA
- 13 Mar 2007 Preclinical trials in Pain in USA (unspecified route)